Completion of a Non-exclusive Discount Agreement According to § 130a Para. 8 Sgb... Tender

Procurement Summary

Country : Germany

Summary : Completion of a Non-exclusive Discount Agreement According to § 130a Para. 8 Sgb V to the Active Substance Insulin Lispro, Atc A10ab04 and A10ad04 for the Time 01.01.2022 - 31.12.2023

Deadline : 05 Nov 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 60118226

Document Ref. No. : 589350-2021

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : EUR 1.00

Purchaser's Detail

Purchaser : DAK HEALTH
Address : Nagelsweg 27-31
Town : Hamburg
NUTS-Code : DE600 - Hamburg
Postal Code : 20097
Phone : +49 402364855-2681
Fax : +49 4033470-900200
Germany
Email :vergabestelle@dak.de
URL :www.dak.de

Tender Details

Document Type: Contract Notice

Title: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for active substance Insulin Lispro, ATC A10AB04 and A10AD04 for the time 01.01.2022 - 31.12.2023

Reference Number: 1003487 - Insulin Lispro, ATC A10AB04 and A10AD04

Contract Type: Supplies

Estimated Value: 1.00 - EUR

Description: § 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to enclose framework contract contracts for the medicinal products to be deducted from the statutory health insurance companies. With regard to the relevant statutory provisions on the award of public contracts, a regular process of drug-related, formal procurement procedures takes place according to the regulations of the 4th part of the GWB by DAK health. For the tenderer in Appendix 2 to the Treaty to Treaty to the Treaty to the o. G. Active substance Insulin Lispro, ATC A10AB04 and A10AD04, intends to enlarge the DAK health until the entry into force of new drug discount agreements with as far as possible to all interested pharmaceutical companies to conclude drug discount agreements. A discount contract IR.D. Admission model to the O ....

Documents

 Tender Notice